An accelerated discovery pipeline for antiviral antibody therapeutics
Watch this webinar to learn how researchers have implemented accelerated discovery and validation of potent therapeutic mAbs
1 Nov 2019
Viral infectious diseases are emerging and re-emerging globally, which underscores the urgent need for accelerated discovery of antiviral therapeutics.
Human antiviral monoclonal antibodies (mAbs) are promising drug candidates for clinical evaluation. High cost and long timelines required to develop therapeutic mAbs remain two of the key challenges.
Join our free educational webinar to learn how researchers at Vanderbilt University have implemented accelerated discovery and validation of potent therapeutic mAbs using an integrated pipeline technology combining flow cytometry, bioinformatics, synthetic biology, and high-throughput analysis.
Register now
Join this webinar, presented by Robert Carnahan, Associate Professor of Pediatrics and Radiology, Vanderbilt University & Pavlo Gilchuk, Senior Staff Scientist, Vanderbilt Vaccine Center, to:
- Gain insight into flow cytometry, bioinformatics, and synthetic biology techniques used for mAb discovery and validation
- Understand the workflow for accelerating mAb therapeutics for use as antiviral agents
Attend the live webinar on Tuesday, November 12, at:
- 15:00 GMT
- 10:00 EST
- 07:00 PST
- 16:00 CET
Certificate of Attendance
All webinar participants can request a certificate of attendance, and a learning outcomes summary document for continuing education purposes.
Find out more on this topic by registering to watch the full webinar>>
SelectScience runs 3-4 webinars a month across various scientific topics, discover more of our upcoming webinars>>
